AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 66 filers reported holding AVROBIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $124,000 | -40.4% | 22,244 | -4.9% | 0.06% | -36.0% |
| Q2 2021 | $208,000 | -26.2% | 23,398 | +5.2% | 0.09% | -27.7% |
| Q1 2021 | $282,000 | -7.5% | 22,244 | +1.8% | 0.12% | -6.3% |
| Q4 2020 | $305,000 | +66.7% | 21,853 | +55.5% | 0.13% | +32.3% |
| Q3 2020 | $183,000 | -34.2% | 14,055 | -11.9% | 0.10% | -27.3% |
| Q2 2020 | $278,000 | +8.6% | 15,955 | -2.9% | 0.13% | +25.7% |
| Q1 2020 | $256,000 | -32.5% | 16,434 | -12.7% | 0.10% | +69.4% |
| Q4 2019 | $379,000 | +44.1% | 18,829 | +0.9% | 0.06% | +17.0% |
| Q3 2019 | $263,000 | -17.8% | 18,656 | -5.3% | 0.05% | -20.9% |
| Q2 2019 | $320,000 | +33.9% | 19,695 | +81.5% | 0.07% | -86.8% |
| Q1 2019 | $239,000 | +17.2% | 10,850 | -11.6% | 0.51% | +1354.3% |
| Q4 2018 | $204,000 | – | 12,277 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,236,123 | $19,234,000 | 16.13% |
| Aisling Capital Management LP | 1,009,779 | $15,712,000 | 6.84% |
| Burrage Capital Management LLC | 225,900 | $3,273,000 | 3.22% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $15,560,000 | 2.18% |
| Parkman Healthcare Partners LLC | 295,593 | $4,599,000 | 2.13% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $4,910,000 | 1.47% |
| Asymmetry Capital Management, L.P. | 85,554 | $1,331,000 | 1.46% |
| Camber Capital Management LP | 1,350,000 | $21,006,000 | 1.25% |
| Pinz Capital Management, LP | 26,531 | $413,000 | 1.08% |
| Vivo Capital, LLC | 717,753 | $11,168,000 | 1.01% |